GO:0061762 CAMKK-AMPK signaling cascade: Calcium-Dependent Stress Kinase Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061762 (CAMKK-AMPK signaling cascade) is the biological process in which calmodulin-dependent protein kinase kinase (CAMKK) directly activates AMP-activated protein kinase (AMPK) in response to calcium and cellular stress.
• The cascade begins with calcium binding to calmodulin, which enables CAMKK catalytic activity, and ends with AMPK phosphorylated and active.
• CAMKK2 (CaMKKbeta) is the principal upstream kinase that phosphorylates AMPK at Thr172 in many cell types, particularly when energy charge is preserved but calcium or oxidant signals rise.
• This pathway links calcium signaling, reactive oxygen species (ROS), and metabolic stress to AMPK-dependent autophagy, migration, and survival decisions [1,5].
• Dysregulation of CAMKK-AMPK signaling has been implicated in cancer, metabolic disorders, asthma, and neurodegenerative conditions such as chorea-acanthocytosis [1,2,3].
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect the causal roles of CAMKK2, AMPK subunits, and downstream effectors in this cascade [1,4,6].
Description
The CAMKK-AMPK signaling cascade (GO:0061762) is a calcium- and stress-responsive kinase pathway that directly couples calmodulin-dependent protein kinase kinase (CAMKK) activity to activation of AMP-activated protein kinase (AMPK). In this cascade, calcium binding to calmodulin enables CAMKK to phosphorylate AMPK, converting a calcium signal into a metabolic and autophagic response. This process is distinct from the canonical LKB1-dependent AMPK activation pathway and is often engaged when cells experience matrix deprivation, oxidant stress, or calcium influx without a severe drop in ATP. The cascade is conserved and operates in diverse contexts, from neuronal migration to tumor cell survival [1,6]. Because AMPK is a central regulator of energy homeostasis, autophagy, and cell polarity, understanding how CAMKK activates AMPK is critical for interpreting calcium-dependent stress responses [1,5]. Researchers study this pathway using genetic models, phospho-specific antibodies, and functional assays that report AMPK activity and downstream autophagy or cytoskeletal changes [1,4,6]. The pathway also intersects with disease processes such as cancer, asthma, and chorea-acanthocytosis, making it a target for mechanistic and translational studies [1,2,3].
CAMKK-AMPK signaling cascade At A Glance
| GO ID | GO:0061762 |
|---|---|
| GO term | CAMKK-AMPK signaling cascade |
| Ontology | biological_process |
| Synonym | stress-activated AMP-activated protein kinase signaling cascade |
| Major function | Calcium- and calmodulin-dependent activation of AMPK by CAMKK |
| Upstream trigger | Calcium binding to calmodulin, which binds and activates CAMKK |
| Downstream effector | AMP-activated protein kinase (AMPK) activity |
| Key kinase | CAMKK2 (CaMKKbeta) as the CAMKK family member most studied in this cascade |
| Cellular context | Stress conditions including matrix deprivation, oxidant stress, and calcium influx |
What Is GO:0061762?
GO:0061762 is defined as the series of molecular signals in which calmodulin-dependent protein kinase activity enabled by a CAMKK directly activates an AMPK. The cascade begins with calmodulin binding calcium, which in turn binds CAMKK, enabling its calmodulin-dependent protein kinase activity. The cascade ends with AMP-activated protein kinase activity. In simpler terms, it is the calcium-triggered route that turns on AMPK through CAMKK.
Why Is CAMKK-AMPK signaling cascade Important in Cell Biology?
The CAMKK-AMPK signaling cascade is important because it provides a direct molecular link between calcium signaling and AMPK-dependent metabolic and autophagic programs, allowing cells to respond to stress even when ATP levels are not severely compromised. This pathway influences cell survival, migration, and autophagy, and its dysregulation has been associated with cancer, metabolic disease, asthma, and neurodegenerative conditions [1,2,3,5]. Understanding this cascade helps researchers interpret how calcium and ROS converge on AMPK and how targeting CAMKK or AMPK may alter disease-relevant phenotypes [1,5].
• Links calcium signaling to AMPK activation independently of LKB1 in many contexts.
• Mediates AMPK activation upon matrix deprivation and oxidant stress.
• Regulates autophagy through AMPK-dependent downstream signaling [1,5].
• Contributes to cell migration and cytoskeletal dynamics in neurons.
• Implicated in cancer cell survival and metabolic adaptation.
• Associated with asthma-related ferroptosis and immune microenvironment gene signatures.
• Identified as a pathway in chorea-acanthocytosis bioinformatic analyses.
• Provides a target for pharmacological modulation of AMPK in metabolic disease.
• Supports studies of omega-3 fatty acid effects on hepatoma steatosis through AMPK-related signaling.
• Enables mechanistic dissection using CRISPR knockout and phospho-mutant models [1,4,6].
What Happens During CAMKK-AMPK signaling cascade?
Calcium binding to calmodulin
In simple terms: Calcium acts like a key that turns on a helper protein called calmodulin.
The cascade is initiated when intracellular calcium rises and binds to calmodulin, forming a calcium-calmodulin complex. This step is the trigger that enables the next kinase in the pathway, CAMKK, to become active.
CAMKK activation by calcium-calmodulin
In simple terms: The calcium-calmodulin complex switches on CAMKK, a kinase that can phosphorylate other proteins.
Calcium-calmodulin binds to CAMKK and enables its calmodulin-dependent protein kinase activity. CAMKK2 (CaMKKbeta) is a well-characterized member of this family that can directly phosphorylate AMPK in response to calcium and oxidant signals.
Direct phosphorylation of AMPK by CAMKK
In simple terms: CAMKK adds a phosphate tag to AMPK, which turns AMPK on.
Activated CAMKK directly phosphorylates AMPK, leading to AMPK activation. This phosphorylation event is the defining step of GO:0061762 and can occur under conditions such as matrix deprivation where AMPK is activated by a calcium-oxidant signaling network.
AMPK activity and downstream responses
In simple terms: Once AMPK is on, it triggers changes in cell metabolism, autophagy, and survival.
The cascade ends with AMP-activated protein kinase activity, which then propagates downstream signals. AMPK activation via this pathway has been linked to autophagy induction and stress responses in various cell types [1,5].
Integration with oxidant and stress signals
In simple terms: Reactive oxygen species can help turn on this pathway alongside calcium.
A calcium-oxidant signaling network regulates AMPK activation upon matrix deprivation, indicating that ROS and calcium cooperate to engage CAMKK-AMPK signaling. This integration allows cells to respond to multiple stress inputs through a common AMPK node.
Key Genes Involved in GO:0061762 CAMKK-AMPK signaling cascade
The following genes and proteins are central to the CAMKK-AMPK signaling cascade or are commonly used as markers and effectors in its study.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase beta that directly phosphorylates and activates AMPK | Primary upstream kinase in GO:0061762; knockout and point-mutation models used to test calcium-dependent AMPK activation |
| CAMKK1 | Calcium/calmodulin-dependent protein kinase kinase alpha, a related CAMKK family member | Potential redundant or tissue-specific activator of AMPK; studied alongside CAMKK2 |
| PRKAA1 | Catalytic alpha-1 subunit of AMPK | Target of CAMKK phosphorylation; knockout and phospho-mutant models assess AMPK dependence |
| PRKAA2 | Catalytic alpha-2 subunit of AMPK | Alternative AMPK catalytic subunit; relevant for tissue-specific AMPK functions |
| PRKAB1 | Non-catalytic beta-1 subunit of AMPK | Scaffold subunit affecting AMPK stability and substrate specificity |
| PRKAB2 | Non-catalytic beta-2 subunit of AMPK | Modulates AMPK complex assembly and downstream signaling |
| PRKAG1 | Non-catalytic gamma-1 subunit of AMPK | Regulatory subunit sensing adenine nucleotides; influences AMPK activation |
| PRKAG2 | Non-catalytic gamma-2 subunit of AMPK | Regulatory subunit with tissue-specific roles in AMPK signaling |
| CALM1 | Calmodulin 1, calcium-binding protein that activates CAMKK | Essential upstream calcium sensor; knockdown or knockout alters cascade initiation |
| CALM2 | Calmodulin 2, calcium-binding protein | Redundant calmodulin isoform contributing to CAMKK activation |
| CALM3 | Calmodulin 3, calcium-binding protein | Calmodulin isoform involved in calcium-dependent CAMKK activation |
| LKB1 (STK11) | Upstream kinase that activates AMPK in an energy-stress-dependent manner | Used as a comparator to distinguish CAMKK-dependent from LKB1-dependent AMPK activation |
| ULK1 | Autophagy-initiating kinase downstream of AMPK | Readout of AMPK-dependent autophagy in CAMKK-AMPK studies |
| BECN1 | Beclin-1, autophagy regulator | Marker of autophagy induction downstream of AMPK activation |
| MAP1LC3B | LC3B, autophagosome marker | Used to monitor autophagy flux following CAMKK-AMPK activation |
| GPR120 (FFAR4) | Omega-3 fatty acid receptor linked to AMPK signaling | Studied in hepatoma steatosis models where AMPK pathways are relevant |
| ACTA2 | Actin cytoskeleton component | Relevant to migration and cytoskeletal studies involving AMPK signaling |
| TUBB3 | Neuronal tubulin isoform | Used in axophilic neuronal migration studies where microtubule tension and AMPK-related pathways are examined |
How Is CAMKK-AMPK signaling cascade Regulated?
The CAMKK-AMPK signaling cascade is regulated at multiple levels. Upstream, calcium availability and calmodulin binding control CAMKK activity, and oxidant signals can cooperate with calcium to enhance AMPK activation upon matrix deprivation. The pathway can be distinguished from LKB1-dependent AMPK activation, which responds primarily to energy stress. Downstream, AMPK activity is modulated by adenine nucleotide levels through its gamma subunits and by phosphorylation events that affect its stability and substrate access. Pharmacological agents such as ursolic acid can induce autophagy via ROS-dependent endoplasmic reticulum stress, which may intersect with AMPK-related signaling. Omega-3 polyunsaturated fatty acids can protect hepatoma cells from steatosis through FFA4 (GPR120), a context in which AMPK signaling is relevant. In disease bioinformatics, ferroptosis-related genes and immune microenvironment signatures have been linked to asthma, and CAMKK-AMPK pathway components may contribute to these networks. Additionally, chorea-acanthocytosis bioinformatic analyses have identified pivotal genes and pathways that may include AMPK-related signaling.
CAMKK-AMPK signaling cascade and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CAMKK2 | Cancer cell survival under matrix deprivation | CRISPR knockout in cancer cell lines followed by matrix-deprivation assays |
| PRKAA1 | Metabolic stress and autophagy | Point-mutation knock-in of phospho-dead or phospho-mimetic AMPK |
| FFAR4 (GPR120) | Hepatoma steatosis and omega-3 response | Overexpression or knockout in hepatoma cells treated with omega-3 fatty acids |
| Ferroptosis-related genes | Asthma and immune microenvironment | Bioinformatic integration with CRISPR library screening in immune cells |
| Chorea-acanthocytosis-associated genes | Neurodegeneration | Patient-derived cells or knockout models for pathway validation |
Cancer and metabolic stress
The CAMKK-AMPK signaling cascade is activated upon matrix deprivation in cancer cells, where a calcium-oxidant signaling network regulates AMPK activation. This pathway supports cancer cell survival and metabolic adaptation under stress, making it a potential target for therapeutic intervention. Studies in hepatoma cells show that omega-3 polyunsaturated fatty acids protect against steatosis through FFA4 (GPR120), a process that involves AMPK-related signaling.
Asthma and immune microenvironment
Ferroptosis-related genes are involved in asthma and regulate the immune microenvironment, and pathway analyses have implicated stress-kinase signaling including AMPK-related networks. The CAMKK-AMPK cascade may contribute to how asthma-related oxidative stress influences immune cell function.
Neurodegeneration and chorea-acanthocytosis
Comprehensive bioinformatic analysis of chorea-acanthocytosis has identified pivotal genes and pathways, with AMPK-related signaling among the pathways potentially involved. Neuronal migration studies show that capture of microtubule plus-ends at the actin cortex promotes axophilic neuronal migration by enhancing microtubule tension, a process that can intersect with AMPK-dependent cytoskeletal regulation.
Autophagy and cell survival
Ursolic acid induces autophagy in U87MG cells via ROS-dependent endoplasmic reticulum stress, a context where AMPK activation can promote autophagic flux. The CAMKK-AMPK cascade is a plausible contributor to autophagy induction under calcium and oxidant stress [1,5].
From CAMKK-AMPK signaling cascade-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is CAMKK2 required for AMPK activation upon matrix deprivation? | CAMKK2 knockout cell lines with phospho-AMPK readout |
| Does phosphorylation of AMPK at a specific residue mediate autophagy? | Point-mutation knock-in of AMPK phospho-acceptor site |
| Can calcium-calmodulin binding to CAMKK be disrupted to block the cascade? | Point mutation in CAMKK calmodulin-binding domain |
| Does overexpression of CAMKK2 enhance AMPK-dependent migration? | CAMKK2 overexpression in neuronal or cancer cells with migration assays |
| What is the role of FFA4 (GPR120) in AMPK-linked steatosis protection? | FFAR4 knockout or overexpression in hepatoma cells |
| Which downstream effectors are required for autophagy induction? | CRISPR knockout of ULK1 or BECN1 in cells with activated CAMKK-AMPK signaling [1,5] |
How to Study the CAMKK-AMPK signaling cascade Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phospho-AMPK immunoblot | AMPK Thr172 phosphorylation | Confirming CAMKK-dependent AMPK activation |
| Calcium imaging | Intracellular calcium levels | Linking calcium signals to CAMKK-AMPK cascade initiation |
| CRISPR knockout | Loss-of-function effects | Testing requirement for CAMKK2 or AMPK subunits |
| Autophagy flux assay | LC3B lipidation and autophagic degradation | Measuring downstream autophagy |
| Migration assay | Cell movement and cytoskeletal dynamics | Studying neuronal migration and AMPK-dependent motility |
| RNA-seq | Transcriptional changes | Identifying pathway signatures in disease models [2,3] |
| Proteomics | Protein phosphorylation and interactions | Mapping CAMKK-AMPK substrate networks |
| Bioinformatic enrichment | Pathway and gene set enrichment | Discovering CAMKK-AMPK involvement in disease datasets [2,3] |
Phospho-specific immunoblotting
Phospho-specific antibodies against AMPK Thr172 and downstream substrates are used to monitor CAMKK-AMPK cascade activation. This method is standard for confirming that CAMKK activity leads to AMPK phosphorylation under calcium or oxidant stress.
Genetic knockout and rescue
CRISPR knockout of CAMKK2 or AMPK subunits followed by rescue with wild-type or mutant constructs allows causal testing of the cascade. This approach distinguishes CAMKK-dependent from LKB1-dependent AMPK activation.
Autophagy flux assays
LC3B lipidation and autophagic flux assays are used to measure downstream consequences of AMPK activation. These assays help link CAMKK-AMPK signaling to autophagy induction [1,5].
Bioinformatic pathway analysis
Transcriptomic and bioinformatic analyses identify CAMKK-AMPK pathway components in disease datasets such as asthma and chorea-acanthocytosis [2,3]. These methods generate hypotheses that can be tested with CRISPR models [2,3].
How CRISPR Can Be Used to Study GO:0061762 CAMKK-AMPK signaling cascade
Knockout
CRISPR knockout of CAMKK2 or AMPK catalytic subunits is used to test whether the CAMKK-AMPK cascade is required for a given phenotype, such as matrix-deprivation-induced AMPK activation. Knockout models provide clean loss-of-function evidence and can be paired with rescue experiments.
Point Mutation
Point mutations in the AMPK phosphorylation site or in the CAMKK calmodulin-binding domain allow precise dissection of the cascade. Phospho-dead and phospho-mimetic mutants help determine whether phosphorylation is necessary or sufficient for downstream effects.
Knock-in
Knock-in of tagged or mutant alleles enables tracking of CAMKK or AMPK localization and activity in live cells. Tagged knock-in models are useful for imaging and proteomic studies of the cascade.
Overexpression
Overexpression of CAMKK2 or constitutively active AMPK mutants can amplify the cascade to study downstream autophagy, migration, and survival [1,6]. Overexpression models are particularly useful when the endogenous signal is weak or transient.
How EDITGENE Supports CAMKK-AMPK signaling cascade Research
Researchers studying CAMKK-AMPK signaling cascade-related genes often need to determine whether a candidate gene is causally involved in calcium-dependent AMPK activation or is merely a correlative marker. Rigorous causal inference requires well-controlled genetic models, including knockout, point-mutation, knock-in, and overexpression cell lines, as well as functional readouts such as phospho-AMPK immunoblotting and autophagy flux assays [1,5]. EDITGENE provides these models and services to accelerate mechanistic and translational studies of GO:0061762.
Contact EDITGENE today to design your custom CRISPR model for CAMKK-AMPK signaling cascade research.
Frequently Asked Questions About CAMKK-AMPK signaling cascade
What is GO:0061762 CAMKK-AMPK signaling cascade?
GO:0061762 is the biological process in which calmodulin-dependent protein kinase kinase (CAMKK) directly activates AMP-activated protein kinase (AMPK) in response to calcium and calmodulin binding.
What genes are involved in CAMKK-AMPK signaling cascade?
Key genes include CAMKK2, CAMKK1, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, and calmodulin genes CALM1, CALM2, and CALM3.
How is AMPK activated by calcium?
Calcium binds calmodulin, which binds and activates CAMKK; CAMKK then directly phosphorylates AMPK, leading to AMPK activity.
What is the difference between CAMKK-AMPK and LKB1-AMPK signaling?
CAMKK-AMPK signaling is calcium-dependent and can activate AMPK under matrix deprivation or oxidant stress, whereas LKB1-AMPK signaling is primarily energy-stress-dependent.
What diseases are associated with CAMKK-AMPK signaling?
This pathway has been implicated in cancer, metabolic stress, asthma, and neurodegenerative conditions such as chorea-acanthocytosis [1,2,3].
How can I study CAMKK-AMPK signaling in the lab?
Common methods include phospho-AMPK immunoblotting, calcium imaging, CRISPR knockout, autophagy flux assays, and bioinformatic pathway analysis [1,5].
What is the role of CAMKK2 in AMPK activation?
CAMKK2 (CaMKKbeta) is a calcium/calmodulin-dependent kinase that directly phosphorylates AMPK and is a principal upstream activator in this cascade.
Can CRISPR be used to model CAMKK-AMPK signaling?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models are widely used to dissect the cascade and its downstream effects [1,4,6].
What are downstream effects of CAMKK-AMPK activation?
Downstream effects include autophagy induction, metabolic adaptation, cell survival, and cytoskeletal changes relevant to migration [1,5,6].
Where can I find validated CRISPR models for CAMKK-AMPK research?
EDITGENE provides validated knockout, point-mutation, knock-in, overexpression, and library screening services for CAMKK-AMPK cascade genes.
Conclusion
The CAMKK-AMPK signaling cascade (GO:0061762) is a calcium- and stress-responsive pathway that directly links CAMKK activity to AMPK activation, influencing autophagy, metabolism, survival, and migration [1,5,6]. Its dysregulation has been associated with cancer, asthma, and neurodegenerative conditions, making it a compelling target for mechanistic and translational research [1,2,3]. Rigorous genetic models, including CRISPR knockout, point-mutation, knock-in, and overexpression cell lines, are essential to establish causality and to identify therapeutic opportunities within this cascade [1,4,6].
References
- 1. Sundararaman A et al.. 2016. Calcium-Oxidant Signaling Network Regulates AMP-activated Protein Kinase (AMPK) Activation upon Matrix Deprivation.. J Biol Chem 291(28):14410-29 PMID: 27226623
- 2. Wang H et al.. 2023. Ferroptosis-related genes are involved in asthma and regulate the immune microenvironment.. Front Pharmacol 14:1087557 PMID: 36843917
- 3. Sharma R et al.. 2024. Identification of pivotal genes and pathways in Chorea-acanthocytosis using comprehensive bioinformatic analysis.. PLoS One 19(9):e0309594 PMID: 39292690
- 4. Kang S et al.. 2018. Omega-3 polyunsaturated fatty acids protect human hepatoma cells from developing steatosis through FFA4 (GPR120).. Biochim Biophys Acta Mol Cell Biol Lipids 1863(2):105-116 PMID: 29126901
- 5. Shen S et al.. 2014. Ursolic acid induces autophagy in U87MG cells via ROS-dependent endoplasmic reticulum stress.. Chem Biol Interact 218:28-41 PMID: 24802810
- 6. Hutchins BI et al.. 2014. Capture of microtubule plus-ends at the actin cortex promotes axophilic neuronal migration by enhancing microtubule tension in the leading process.. Front Cell Neurosci 8:400 PMID: 25505874
